

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.90764225 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.90764225 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.64559947 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64559947 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.11706753 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.03835924 |
| 7 | exogenous drug catabolic process (GO:0042738) | 5.98711542 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 5.77279336 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.68655972 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53308821 |
| 11 | lysine catabolic process (GO:0006554) | 5.50812025 |
| 12 | lysine metabolic process (GO:0006553) | 5.50812025 |
| 13 | cysteine metabolic process (GO:0006534) | 5.45254829 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.41698677 |
| 15 | tryptophan catabolic process (GO:0006569) | 5.40429384 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 5.40429384 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 5.40429384 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.36902821 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.34682671 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.17759983 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.15588098 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.12887863 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.78895751 |
| 24 | urea metabolic process (GO:0019627) | 4.77235995 |
| 25 | urea cycle (GO:0000050) | 4.77235995 |
| 26 | amino-acid betaine metabolic process (GO:0006577) | 4.71799936 |
| 27 | ethanol metabolic process (GO:0006067) | 4.71774263 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.67284265 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.58341187 |
| 30 | protein carboxylation (GO:0018214) | 4.57310249 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.57310249 |
| 32 | bile acid metabolic process (GO:0008206) | 4.55718897 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.51576215 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.49257301 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 4.48998806 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.48998695 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.48355219 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.44976696 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.41878564 |
| 40 | regulation of plasminogen activation (GO:0010755) | 4.40240289 |
| 41 | * homocysteine metabolic process (GO:0050667) | 4.34630589 |
| 42 | regulation of fibrinolysis (GO:0051917) | 4.34567651 |
| 43 | ethanol oxidation (GO:0006069) | 4.33431338 |
| 44 | * fatty acid beta-oxidation (GO:0006635) | 4.32106521 |
| 45 | * short-chain fatty acid metabolic process (GO:0046459) | 4.31296901 |
| 46 | acetyl-CoA metabolic process (GO:0006084) | 4.30918887 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.29840224 |
| 48 | cellular amino acid catabolic process (GO:0009063) | 4.26278049 |
| 49 | fibrinolysis (GO:0042730) | 4.25020203 |
| 50 | regulation of complement activation (GO:0030449) | 4.23080001 |
| 51 | valine metabolic process (GO:0006573) | 4.22295554 |
| 52 | aspartate family amino acid catabolic process (GO:0009068) | 4.21510859 |
| 53 | * fatty acid oxidation (GO:0019395) | 4.16129654 |
| 54 | oxidative demethylation (GO:0070989) | 4.15392161 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 4.14945813 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.14268103 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.14268103 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.10529125 |
| 59 | * lipid oxidation (GO:0034440) | 4.09397791 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 4.07844380 |
| 61 | glutamate metabolic process (GO:0006536) | 4.06027178 |
| 62 | S-adenosylmethionine metabolic process (GO:0046500) | 4.05471986 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 4.04073660 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.01714995 |
| 65 | macromolecular complex remodeling (GO:0034367) | 4.01714995 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.01714995 |
| 67 | * fatty acid catabolic process (GO:0009062) | 4.01694825 |
| 68 | branched-chain amino acid catabolic process (GO:0009083) | 4.00569342 |
| 69 | reverse cholesterol transport (GO:0043691) | 3.99517151 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 3.99278193 |
| 71 | ketone body metabolic process (GO:1902224) | 3.99191818 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.97822116 |
| 73 | * monocarboxylic acid catabolic process (GO:0072329) | 3.95320347 |
| 74 | glycine metabolic process (GO:0006544) | 3.92894132 |
| 75 | * organic acid catabolic process (GO:0016054) | 3.92809734 |
| 76 | * carboxylic acid catabolic process (GO:0046395) | 3.92809734 |
| 77 | drug transmembrane transport (GO:0006855) | 3.92293276 |
| 78 | regulation of cholesterol esterification (GO:0010872) | 3.91191690 |
| 79 | cellular glucuronidation (GO:0052695) | 3.90679771 |
| 80 | phenylpropanoid metabolic process (GO:0009698) | 3.89173058 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 3.83381899 |
| 82 | branched-chain amino acid metabolic process (GO:0009081) | 3.81698500 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 3.81191198 |
| 84 | carnitine metabolic process (GO:0009437) | 3.80601909 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.79431729 |
| 86 | negative regulation of sterol transport (GO:0032372) | 3.77284986 |
| 87 | negative regulation of cholesterol transport (GO:0032375) | 3.77284986 |
| 88 | drug catabolic process (GO:0042737) | 3.75899481 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.75389586 |
| 90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74028723 |
| 91 | amine catabolic process (GO:0009310) | 3.68396788 |
| 92 | cellular biogenic amine catabolic process (GO:0042402) | 3.68396788 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.66454832 |
| 94 | urate metabolic process (GO:0046415) | 3.64951350 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.61483466 |
| 96 | biotin metabolic process (GO:0006768) | 3.61193805 |
| 97 | phospholipid efflux (GO:0033700) | 3.59792359 |
| 98 | fatty acid transmembrane transport (GO:1902001) | 3.57999703 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.55732259 |
| 100 | aldehyde catabolic process (GO:0046185) | 3.55699483 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.51183791 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.51183791 |
| 103 | imidazole-containing compound metabolic process (GO:0052803) | 3.47215912 |
| 104 | heme transport (GO:0015886) | 3.46243689 |
| 105 | negative regulation of protein activation cascade (GO:2000258) | 3.45563930 |
| 106 | regulation of cholesterol metabolic process (GO:0090181) | 3.41405071 |
| 107 | polyketide metabolic process (GO:0030638) | 3.38902316 |
| 108 | doxorubicin metabolic process (GO:0044598) | 3.38902316 |
| 109 | daunorubicin metabolic process (GO:0044597) | 3.38902316 |
| 110 | cholesterol efflux (GO:0033344) | 3.38585590 |
| 111 | low-density lipoprotein particle remodeling (GO:0034374) | 3.38547853 |
| 112 | drug metabolic process (GO:0017144) | 3.38381804 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.36765133 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.36731424 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.35287998 |
| 116 | positive regulation of fatty acid oxidation (GO:0046321) | 3.34089541 |
| 117 | cofactor catabolic process (GO:0051187) | 3.33584714 |
| 118 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.30686106 |
| 119 | peroxisome fission (GO:0016559) | 3.18463917 |
| 120 | COPII vesicle coating (GO:0048208) | 3.15247951 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.10181410 |
| 122 | protein activation cascade (GO:0072376) | 3.07790661 |
| 123 | negative regulation of hemostasis (GO:1900047) | 3.05718041 |
| 124 | negative regulation of blood coagulation (GO:0030195) | 3.05718041 |
| 125 | response to mercury ion (GO:0046689) | 3.04390318 |
| 126 | primary alcohol catabolic process (GO:0034310) | 3.03075886 |
| 127 | primary alcohol metabolic process (GO:0034308) | 3.00602979 |
| 128 | tricarboxylic acid cycle (GO:0006099) | 2.98786730 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.89880257 |
| 130 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.89880257 |
| 131 | oxaloacetate metabolic process (GO:0006107) | 2.88241772 |
| 132 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.88039495 |
| 133 | complement activation, classical pathway (GO:0006958) | 2.87667504 |
| 134 | negative regulation of complement activation (GO:0045916) | 2.87354393 |
| 135 | negative regulation of wound healing (GO:0061045) | 2.85098312 |
| 136 | negative regulation of coagulation (GO:0050819) | 2.81745616 |
| 137 | complement activation (GO:0006956) | 2.81200989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.71998416 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66425494 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.60920685 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.11166965 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.94909950 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.76906670 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.39143072 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83842007 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.82461809 |
| 10 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.34233369 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.11437466 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.54829345 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20799429 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.20427706 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10571163 |
| 16 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.10427571 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01992107 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9297291 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.92430729 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86299751 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.86082418 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77217947 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70274981 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65900560 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58440171 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56673893 |
| 27 | * GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49676335 |
| 28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49474772 |
| 29 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48781094 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42263960 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41199879 |
| 32 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.40088700 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39892476 |
| 34 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.38564707 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37745616 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37677670 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36569625 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34870073 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33512184 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33094543 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25459632 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23906446 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23670016 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19855456 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19855456 |
| 46 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19049520 |
| 47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19001814 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18528087 |
| 49 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.15722667 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12922006 |
| 51 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12158092 |
| 52 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.11547134 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11390323 |
| 54 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.09437436 |
| 55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08356208 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07512801 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06873640 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06550752 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06369312 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04878589 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04830845 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04480247 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04157355 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03318400 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02969417 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02016689 |
| 67 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.01933766 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00973965 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00329081 |
| 70 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00211449 |
| 71 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00166794 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99362159 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99340202 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97676912 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97676912 |
| 76 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.97631823 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97409457 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96854083 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96786656 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96492001 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96088764 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94897842 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94654488 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94578430 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94308783 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92984824 |
| 87 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92769822 |
| 88 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92709000 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92528541 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92106846 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91850317 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91251195 |
| 93 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.91053303 |
| 94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90740653 |
| 95 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90685435 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90581711 |
| 97 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90239564 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89881535 |
| 99 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89858703 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89079598 |
| 101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88982001 |
| 102 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88734848 |
| 103 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.88039585 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87419763 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85632428 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83134440 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80700705 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75071194 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75071194 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74639915 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71399922 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71111950 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70871753 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70749581 |
| 115 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70053642 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.65969515 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65864086 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63637637 |
| 119 | CBP_21632823_ChIP-Seq_H3396_Human | 0.63420273 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63333224 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63207093 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62452304 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62161286 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.62100423 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.61190674 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59955679 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59749027 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58109444 |
| 129 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.56474918 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.55997344 |
| 131 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.54589832 |
| 132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53977909 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53196004 |
| 134 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52872259 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.52743773 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.52427537 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52084303 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51480746 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51152881 |
| 140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50332614 |
| 141 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50302469 |
| 142 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.48971285 |
| 143 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.48704518 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48638475 |
| 145 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48292444 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48109309 |
| 147 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48081505 |
| 148 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.47311490 |
| 149 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.47130192 |
| 150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46752967 |
| 151 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46478350 |
| 152 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.46148830 |
| 153 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43716310 |
| 154 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.43586941 |
| 155 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.43529895 |
| 156 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43350005 |
| 157 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.42402630 |
| 158 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41824977 |
| 159 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41124830 |
| 160 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40667513 |
| 161 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.40228225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.61125927 |
| 2 | MP0005360_urolithiasis | 7.07819019 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.82556785 |
| 4 | MP0005365_abnormal_bile_salt | 5.67895006 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.63566622 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.10105792 |
| 7 | MP0003252_abnormal_bile_duct | 3.64834472 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41578552 |
| 9 | * MP0005332_abnormal_amino_acid | 3.09610727 |
| 10 | MP0003195_calcinosis | 3.06827115 |
| 11 | MP0005083_abnormal_biliary_tract | 2.74755097 |
| 12 | MP0009840_abnormal_foam_cell | 2.73096089 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56567781 |
| 14 | MP0002118_abnormal_lipid_homeostasis | 2.22586812 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.22024901 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.06724122 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.02203477 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.93576204 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.87701442 |
| 20 | MP0005670_abnormal_white_adipose | 1.82828546 |
| 21 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71706882 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.69779041 |
| 23 | MP0004130_abnormal_muscle_cell | 1.65526382 |
| 24 | MP0003868_abnormal_feces_composition | 1.63273984 |
| 25 | * MP0009643_abnormal_urine_homeostasis | 1.62404229 |
| 26 | MP0001764_abnormal_homeostasis | 1.61586387 |
| 27 | MP0003186_abnormal_redox_activity | 1.58924089 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.44360722 |
| 29 | MP0005666_abnormal_adipose_tissue | 1.33688197 |
| 30 | * MP0006036_abnormal_mitochondrial_physio | 1.30270855 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.25234995 |
| 32 | MP0005451_abnormal_body_composition | 1.23515483 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.21956518 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.21500477 |
| 35 | MP0000751_myopathy | 1.21329564 |
| 36 | MP0009697_abnormal_copulation | 1.21165234 |
| 37 | MP0002971_abnormal_brown_adipose | 1.17787660 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.15332326 |
| 39 | MP0005187_abnormal_penis_morphology | 1.13806366 |
| 40 | MP0003011_delayed_dark_adaptation | 1.09527689 |
| 41 | MP0001661_extended_life_span | 1.08690735 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.06847789 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.06676169 |
| 44 | * MP0000598_abnormal_liver_morphology | 1.05997923 |
| 45 | MP0005535_abnormal_body_temperature | 1.03190224 |
| 46 | MP0001756_abnormal_urination | 1.02827616 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 1.01319311 |
| 48 | MP0005647_abnormal_sex_gland | 1.00889081 |
| 49 | MP0005367_renal/urinary_system_phenotyp | 1.00479485 |
| 50 | MP0000516_abnormal_urinary_system | 1.00479485 |
| 51 | MP0001984_abnormal_olfaction | 0.98345668 |
| 52 | MP0003718_maternal_effect | 0.97903946 |
| 53 | MP0010386_abnormal_urinary_bladder | 0.97629970 |
| 54 | MP0002876_abnormal_thyroid_physiology | 0.94645962 |
| 55 | MP0000604_amyloidosis | 0.94298621 |
| 56 | MP0003690_abnormal_glial_cell | 0.92610119 |
| 57 | MP0005334_abnormal_fat_pad | 0.91285613 |
| 58 | MP0003880_abnormal_central_pattern | 0.90940713 |
| 59 | MP0003941_abnormal_skin_development | 0.90373407 |
| 60 | * MP0004043_abnormal_pH_regulation | 0.89534999 |
| 61 | MP0004270_analgesia | 0.88658119 |
| 62 | MP0009764_decreased_sensitivity_to | 0.88569615 |
| 63 | MP0009763_increased_sensitivity_to | 0.87596714 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.87338375 |
| 65 | MP0002638_abnormal_pupillary_reflex | 0.85672520 |
| 66 | * MP0009642_abnormal_blood_homeostasis | 0.85208617 |
| 67 | MP0010368_abnormal_lymphatic_system | 0.83188272 |
| 68 | MP0005408_hypopigmentation | 0.82492802 |
| 69 | MP0002090_abnormal_vision | 0.82320324 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.81676579 |
| 71 | MP0003950_abnormal_plasma_membrane | 0.79708766 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.79036388 |
| 73 | MP0001188_hyperpigmentation | 0.77550445 |
| 74 | MP0002254_reproductive_system_inflammat | 0.76773173 |
| 75 | MP0005266_abnormal_metabolism | 0.76717038 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.76449954 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.74904758 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.73933691 |
| 79 | MP0008469_abnormal_protein_level | 0.73886141 |
| 80 | MP0003122_maternal_imprinting | 0.73509048 |
| 81 | MP0004272_abnormal_basement_membrane | 0.72282829 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.71919571 |
| 83 | MP0005330_cardiomyopathy | 0.71420814 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.70938269 |
| 85 | MP0002822_catalepsy | 0.69018222 |
| 86 | MP0003329_amyloid_beta_deposits | 0.68569320 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.68384626 |
| 88 | MP0003646_muscle_fatigue | 0.68024799 |
| 89 | * MP0002136_abnormal_kidney_physiology | 0.66705545 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.65795682 |
| 91 | MP0005448_abnormal_energy_balance | 0.65450276 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.64099256 |
| 93 | MP0000749_muscle_degeneration | 0.62676908 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.61971697 |
| 95 | MP0001529_abnormal_vocalization | 0.59251521 |
| 96 | MP0005409_darkened_coat_color | 0.59242349 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.58204867 |
| 98 | MP0009115_abnormal_fat_cell | 0.57842607 |
| 99 | MP0008995_early_reproductive_senescence | 0.57370475 |
| 100 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57301853 |
| 101 | * MP0005220_abnormal_exocrine_pancreas | 0.56558894 |
| 102 | MP0002269_muscular_atrophy | 0.56474925 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.54816129 |
| 104 | MP0000647_abnormal_sebaceous_gland | 0.54682014 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.52096690 |
| 106 | MP0003953_abnormal_hormone_level | 0.52082726 |
| 107 | MP0004147_increased_porphyrin_level | 0.52051861 |
| 108 | * MP0002069_abnormal_eating/drinking_beha | 0.51525522 |
| 109 | MP0002970_abnormal_white_adipose | 0.49797652 |
| 110 | MP0008872_abnormal_physiological_respon | 0.49165570 |
| 111 | MP0004085_abnormal_heartbeat | 0.48831659 |
| 112 | MP0003890_abnormal_embryonic-extraembry | 0.48081264 |
| 113 | MP0005551_abnormal_eye_electrophysiolog | 0.47953067 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.47184011 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.46351968 |
| 116 | MP0005452_abnormal_adipose_tissue | 0.46318714 |
| 117 | MP0002168_other_aberrant_phenotype | 0.45511853 |
| 118 | MP0006138_congestive_heart_failure | 0.45485510 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.44889426 |
| 120 | MP0003959_abnormal_lean_body | 0.44846804 |
| 121 | MP0002796_impaired_skin_barrier | 0.43914894 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.43610038 |
| 123 | MP0005395_other_phenotype | 0.43095152 |
| 124 | MP0002928_abnormal_bile_duct | 0.42848233 |
| 125 | MP0008438_abnormal_cutaneous_collagen | 0.42704796 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.42508675 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.40742749 |
| 128 | MP0005253_abnormal_eye_physiology | 0.40690594 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.39935358 |
| 130 | MP0005385_cardiovascular_system_phenoty | 0.39419899 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.39419899 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.38784813 |
| 133 | MP0003724_increased_susceptibility_to | 0.38531116 |
| 134 | MP0000747_muscle_weakness | 0.38461320 |
| 135 | MP0003075_altered_response_to | 0.38289453 |
| 136 | MP0009053_abnormal_anal_canal | 0.37446106 |
| 137 | MP0003221_abnormal_cardiomyocyte_apopto | 0.37198729 |
| 138 | MP0004087_abnormal_muscle_fiber | 0.37051199 |
| 139 | MP0008874_decreased_physiological_sensi | 0.36971761 |
| 140 | MP0005620_abnormal_muscle_contractility | 0.35714847 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.35692134 |
| 142 | MP0005165_increased_susceptibility_to | 0.35020721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.32789333 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.31687080 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.94461282 |
| 4 | Xanthomatosis (HP:0000991) | 5.65593806 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.45029003 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.16491390 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.13651519 |
| 8 | Hyperglycinuria (HP:0003108) | 5.08634699 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.86386509 |
| 10 | * Hyperammonemia (HP:0001987) | 4.81912332 |
| 11 | * Ketosis (HP:0001946) | 4.67103331 |
| 12 | Complement deficiency (HP:0004431) | 4.57038323 |
| 13 | * Abnormality of glycine metabolism (HP:0010895) | 4.56735877 |
| 14 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 4.56735877 |
| 15 | Hypoglycemic coma (HP:0001325) | 4.55947096 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.22118475 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.21272428 |
| 18 | * Hyperglycinemia (HP:0002154) | 4.20156473 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.19973084 |
| 20 | Epidermoid cyst (HP:0200040) | 4.05933166 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.02047634 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93577391 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.92996704 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.83958739 |
| 25 | * Ketoacidosis (HP:0001993) | 3.76933787 |
| 26 | Joint hemorrhage (HP:0005261) | 3.72226073 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.70676271 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.68861798 |
| 29 | Fat malabsorption (HP:0002630) | 3.63908263 |
| 30 | Increased serum pyruvate (HP:0003542) | 3.63370011 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.62370995 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.37291155 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35588884 |
| 34 | * Dicarboxylic aciduria (HP:0003215) | 3.28998918 |
| 35 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.28998918 |
| 36 | Gout (HP:0001997) | 3.26292943 |
| 37 | Abnormality of complement system (HP:0005339) | 3.21300369 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.10877480 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.10201538 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.05516326 |
| 41 | * Abnormality of serum amino acid levels (HP:0003112) | 3.03631876 |
| 42 | * Metabolic acidosis (HP:0001942) | 3.02893529 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01654720 |
| 44 | Cerebral edema (HP:0002181) | 3.01053810 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 2.97802244 |
| 46 | * Lethargy (HP:0001254) | 2.96154475 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.91470868 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.84561084 |
| 49 | Proximal tubulopathy (HP:0000114) | 2.77111512 |
| 50 | Steatorrhea (HP:0002570) | 2.76914861 |
| 51 | Skin nodule (HP:0200036) | 2.75421891 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.72823252 |
| 53 | Hyperalaninemia (HP:0003348) | 2.72823252 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.72823252 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.69648418 |
| 56 | Myoglobinuria (HP:0002913) | 2.68647749 |
| 57 | Osteomalacia (HP:0002749) | 2.59045170 |
| 58 | Hyperphosphaturia (HP:0003109) | 2.56310414 |
| 59 | Vascular calcification (HP:0004934) | 2.54754687 |
| 60 | * Abnormality of vitamin metabolism (HP:0100508) | 2.52740342 |
| 61 | * Vomiting (HP:0002013) | 2.52506389 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.51506755 |
| 63 | Myocardial infarction (HP:0001658) | 2.49550689 |
| 64 | Increased purine levels (HP:0004368) | 2.41501534 |
| 65 | Hyperuricemia (HP:0002149) | 2.41501534 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.38103938 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.38103938 |
| 68 | Spastic diplegia (HP:0001264) | 2.34334255 |
| 69 | * Delayed CNS myelination (HP:0002188) | 2.33461702 |
| 70 | Glycosuria (HP:0003076) | 2.30865597 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.30865597 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.30297818 |
| 73 | Enlarged kidneys (HP:0000105) | 2.29597985 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.29595113 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.28654729 |
| 76 | Irritability (HP:0000737) | 2.28198052 |
| 77 | Renal cortical cysts (HP:0000803) | 2.27725242 |
| 78 | Alkalosis (HP:0001948) | 2.25285639 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.24081937 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.23811389 |
| 81 | Cholelithiasis (HP:0001081) | 2.21522907 |
| 82 | Neonatal onset (HP:0003623) | 2.20815673 |
| 83 | Late onset (HP:0003584) | 2.19409776 |
| 84 | Malnutrition (HP:0004395) | 2.15363443 |
| 85 | Nausea (HP:0002018) | 2.12612469 |
| 86 | * Pancreatitis (HP:0001733) | 2.10827589 |
| 87 | Spontaneous abortion (HP:0005268) | 2.07535965 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.05030259 |
| 89 | Hepatic necrosis (HP:0002605) | 2.00523109 |
| 90 | Abnormal cartilage morphology (HP:0002763) | 1.99976748 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 1.99315076 |
| 92 | Atrioventricular block (HP:0001678) | 1.99279643 |
| 93 | Acanthocytosis (HP:0001927) | 1.98793630 |
| 94 | Rhabdomyolysis (HP:0003201) | 1.98599637 |
| 95 | Cholecystitis (HP:0001082) | 1.97576420 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.97576420 |
| 97 | Brushfield spots (HP:0001088) | 1.96867121 |
| 98 | Acute encephalopathy (HP:0006846) | 1.96679670 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 1.94197732 |
| 100 | Fair hair (HP:0002286) | 1.90602983 |
| 101 | Esophageal varix (HP:0002040) | 1.90554062 |
| 102 | Symptomatic seizures (HP:0011145) | 1.88943566 |
| 103 | Exercise-induced muscle cramps (HP:0003710) | 1.87340930 |
| 104 | Amyloidosis (HP:0011034) | 1.86729277 |
| 105 | Rickets (HP:0002748) | 1.86370031 |
| 106 | Hyperglycemia (HP:0003074) | 1.85800136 |
| 107 | Glomerulonephritis (HP:0000099) | 1.85484043 |
| 108 | Hypertriglyceridemia (HP:0002155) | 1.84950124 |
| 109 | Acute hepatic failure (HP:0006554) | 1.82376598 |
| 110 | Opisthotonus (HP:0002179) | 1.81761818 |
| 111 | Mitral stenosis (HP:0001718) | 1.81635462 |
| 112 | Abnormality of the gallbladder (HP:0005264) | 1.80605574 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.79529404 |
| 114 | Nephritis (HP:0000123) | 1.78280264 |
| 115 | Increased muscle lipid content (HP:0009058) | 1.77480928 |
| 116 | Papillary thyroid carcinoma (HP:0002895) | 1.75601086 |
| 117 | Megaloblastic anemia (HP:0001889) | 1.74477503 |
| 118 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.72638621 |
| 119 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71482130 |
| 120 | Rimmed vacuoles (HP:0003805) | 1.63352712 |
| 121 | Renal tubular dysfunction (HP:0000124) | 1.62887078 |
| 122 | Back pain (HP:0003418) | 1.61778231 |
| 123 | Cortical dysplasia (HP:0002539) | 1.61560496 |
| 124 | Neonatal hypoglycemia (HP:0001998) | 1.58291065 |
| 125 | Azoospermia (HP:0000027) | 1.57354105 |
| 126 | Abnormal delivery (HP:0001787) | 1.50283853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.62285481 |
| 2 | SIK1 | 3.81358934 |
| 3 | FGFR4 | 3.11712882 |
| 4 | ERN1 | 2.96768316 |
| 5 | TRIM28 | 2.83657333 |
| 6 | EIF2AK3 | 2.71477737 |
| 7 | ERBB3 | 2.68157589 |
| 8 | INSRR | 2.59958870 |
| 9 | PKN2 | 2.55398002 |
| 10 | TRIB3 | 2.45902850 |
| 11 | PDK4 | 2.27174110 |
| 12 | PDK3 | 2.27174110 |
| 13 | WNK4 | 2.23051321 |
| 14 | EIF2AK1 | 2.03078270 |
| 15 | BCR | 1.99471563 |
| 16 | MAP4K2 | 1.98639038 |
| 17 | MST1R | 1.97016694 |
| 18 | FLT3 | 1.92628857 |
| 19 | ERBB4 | 1.85196877 |
| 20 | FRK | 1.79236337 |
| 21 | TAOK3 | 1.75840299 |
| 22 | BRSK2 | 1.70611429 |
| 23 | OXSR1 | 1.70280993 |
| 24 | PINK1 | 1.63789282 |
| 25 | CCNB1 | 1.53521508 |
| 26 | MAP2K4 | 1.51696862 |
| 27 | CASK | 1.50984139 |
| 28 | NEK1 | 1.48148938 |
| 29 | CAMK1D | 1.48027485 |
| 30 | LATS1 | 1.47872717 |
| 31 | PIK3CG | 1.45842995 |
| 32 | WNK3 | 1.45016105 |
| 33 | PDK2 | 1.43891398 |
| 34 | NEK9 | 1.42951272 |
| 35 | MAPK11 | 1.42789088 |
| 36 | STK39 | 1.39312056 |
| 37 | MARK1 | 1.39168665 |
| 38 | FGFR2 | 1.37828527 |
| 39 | PRKAA2 | 1.36767432 |
| 40 | OBSCN | 1.27789410 |
| 41 | MET | 1.27054271 |
| 42 | PBK | 1.23677802 |
| 43 | PTK6 | 1.22823196 |
| 44 | STK38L | 1.22740255 |
| 45 | CSNK1G2 | 1.18558839 |
| 46 | LMTK2 | 1.18194947 |
| 47 | GRK1 | 1.17851498 |
| 48 | TTK | 1.17311647 |
| 49 | ACVR1B | 1.17208418 |
| 50 | TIE1 | 1.13516104 |
| 51 | TTN | 1.11968187 |
| 52 | ABL2 | 1.11809402 |
| 53 | MAP3K7 | 1.11479566 |
| 54 | ARAF | 1.07524949 |
| 55 | CSNK1G3 | 1.06874714 |
| 56 | TESK2 | 1.06680369 |
| 57 | MAP3K4 | 1.02507454 |
| 58 | NTRK3 | 1.02319740 |
| 59 | JAK2 | 0.99415765 |
| 60 | MYLK | 0.98164245 |
| 61 | MAP3K12 | 0.97585356 |
| 62 | PHKG2 | 0.97388651 |
| 63 | PHKG1 | 0.97388651 |
| 64 | EPHB1 | 0.96616993 |
| 65 | PLK2 | 0.94902067 |
| 66 | MAP3K3 | 0.93718057 |
| 67 | LIMK1 | 0.91803174 |
| 68 | TYK2 | 0.91718758 |
| 69 | PRKAA1 | 0.89842138 |
| 70 | BRSK1 | 0.87915874 |
| 71 | PRKCE | 0.86795118 |
| 72 | MST4 | 0.84936173 |
| 73 | CAMKK2 | 0.84139164 |
| 74 | KDR | 0.82989385 |
| 75 | PIK3CA | 0.82321818 |
| 76 | MAP2K3 | 0.81209418 |
| 77 | BRAF | 0.80284407 |
| 78 | PNCK | 0.79934720 |
| 79 | CAMK1G | 0.78686262 |
| 80 | SGK223 | 0.77364704 |
| 81 | SGK494 | 0.77364704 |
| 82 | CAMK2D | 0.77135506 |
| 83 | MAP2K7 | 0.76667525 |
| 84 | RIPK1 | 0.76231083 |
| 85 | WEE1 | 0.76048109 |
| 86 | JAK1 | 0.75047145 |
| 87 | MINK1 | 0.74917445 |
| 88 | PRKACG | 0.74862205 |
| 89 | SCYL2 | 0.73071512 |
| 90 | GSK3A | 0.72981111 |
| 91 | CSNK1A1L | 0.72843067 |
| 92 | PDPK1 | 0.72607699 |
| 93 | SGK3 | 0.72406498 |
| 94 | MAPK12 | 0.72049371 |
| 95 | CSNK1E | 0.70694597 |
| 96 | DAPK2 | 0.69711723 |
| 97 | TGFBR2 | 0.67648500 |
| 98 | MUSK | 0.67433846 |
| 99 | PRKCG | 0.67406373 |
| 100 | PLK1 | 0.66477233 |
| 101 | PAK3 | 0.64984083 |
| 102 | CDK9 | 0.64193084 |
| 103 | PLK3 | 0.63710990 |
| 104 | MAP3K2 | 0.63604852 |
| 105 | CAMK2G | 0.61964344 |
| 106 | AKT2 | 0.61816233 |
| 107 | EIF2AK2 | 0.60486258 |
| 108 | SGK2 | 0.59133074 |
| 109 | PDGFRA | 0.58560228 |
| 110 | TESK1 | 0.57680646 |
| 111 | EPHA3 | 0.56736947 |
| 112 | SRPK1 | 0.56203292 |
| 113 | PRKCZ | 0.55632909 |
| 114 | CAMK2A | 0.55134271 |
| 115 | MAP2K1 | 0.52626052 |
| 116 | UHMK1 | 0.52213823 |
| 117 | CDK6 | 0.51332310 |
| 118 | ERBB2 | 0.51198099 |
| 119 | TRPM7 | 0.51182063 |
| 120 | MAPK4 | 0.51047622 |
| 121 | FER | 0.50811958 |
| 122 | NEK6 | 0.50550129 |
| 123 | CSNK1A1 | 0.50157329 |
| 124 | MAP3K5 | 0.47974028 |
| 125 | CSNK1G1 | 0.47806639 |
| 126 | CAMK2B | 0.47781062 |
| 127 | PDK1 | 0.45959224 |
| 128 | FGFR3 | 0.45523275 |
| 129 | RET | 0.44239607 |
| 130 | MAPK15 | 0.43584820 |
| 131 | IGF1R | 0.42995686 |
| 132 | KSR1 | 0.41255172 |
| 133 | PRKCQ | 0.41177523 |
| 134 | PRKD1 | 0.40523282 |
| 135 | MOS | 0.39470080 |
| 136 | TNIK | 0.38644748 |
| 137 | CSNK2A2 | 0.38431083 |
| 138 | YES1 | 0.37793562 |
| 139 | NTRK2 | 0.37461419 |
| 140 | IRAK1 | 0.36281389 |
| 141 | DYRK1B | 0.34393247 |
| 142 | PTK2 | 0.34157575 |
| 143 | IRAK2 | 0.33006303 |
| 144 | LRRK2 | 0.32178769 |
| 145 | TBK1 | 0.32076893 |
| 146 | AKT3 | 0.30197144 |
| 147 | MAPK7 | 0.30048319 |
| 148 | GRK6 | 0.29775256 |
| 149 | PKN1 | 0.29137655 |
| 150 | PRKACB | 0.28689434 |
| 151 | PRKACA | 0.28519952 |
| 152 | MTOR | 0.27748423 |
| 153 | CSK | 0.27616838 |
| 154 | IRAK3 | 0.25727307 |
| 155 | MAP2K6 | 0.25370358 |
| 156 | EPHA4 | 0.25185087 |
| 157 | STK38 | 0.23275613 |
| 158 | CAMK4 | 0.22055230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.82942726 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39284585 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01046283 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98077163 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.95795473 |
| 6 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94663544 |
| 7 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73997354 |
| 8 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.70639300 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63999279 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61927557 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59389516 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47670657 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37132878 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32427848 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.18313206 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17460813 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13762353 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12550402 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07534717 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93209263 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91367897 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84813812 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79074261 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67189818 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.66527153 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66488156 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66259405 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65516736 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58824411 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58252677 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57983821 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56907448 |
| 33 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.49146266 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47781695 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45740371 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42008289 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41728327 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41172066 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.39495179 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37552154 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36020425 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32485775 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26860317 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26370506 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18367393 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17032821 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15934140 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06225965 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06225647 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04982993 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04621494 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.04028420 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00705208 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96041000 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91680128 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89287691 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.87549633 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86363818 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86236811 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82965212 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75067096 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73919348 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72008174 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71699554 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57098534 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52997624 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52933321 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46559986 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41571642 |
| 70 | Protein export_Homo sapiens_hsa03060 | 0.40706092 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.37314855 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35940544 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32602499 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31978635 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30495299 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30261576 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27409006 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24986725 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23243393 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20572204 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20045137 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19897385 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.19479163 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16512304 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.15753538 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.14116947 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.13021629 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12425684 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10739901 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10419087 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.07256540 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.06240554 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.04493286 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03168469 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02660388 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.02127951 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01760992 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.01758804 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.00215160 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1595708 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1587762 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | -0.1483185 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1377092 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1282858 |
| 105 | Lysosome_Homo sapiens_hsa04142 | -0.1227259 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1033818 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1014677 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0992820 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0855175 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0766480 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0719872 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0625270 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0497516 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0345525 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0305792 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0068757 |

